OCULAR THERAPEUTIX, INC Net Cash Provided by (Used in) Financing Activities in USD from 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ocular Therapeutix, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to Q1 2025.
  • Ocular Therapeutix, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $4.18M, a 98.7% decline year-over-year.
  • Ocular Therapeutix, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $332M, a 95.6% increase from 2023.
  • Ocular Therapeutix, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $170M, a 11580% increase from 2022.
  • Ocular Therapeutix, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.45M, a 49% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

OCULAR THERAPEUTIX, INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $4.18M -$317M -98.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 $321M +$321M +411724% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 $78K -$51K -39.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $129K +$1.29M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 -$1.16M -$14M -109% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $12.8M -$29.5M -69.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $42.3M +$8.07M +23.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $34.2M +$5.75M +20.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $28.5M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08

OCULAR THERAPEUTIX, INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $332M +$162M +95.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 $170M +$168M +11580% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 $1.45M -$1.4M -49% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 $2.85M -$225M -98.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-11
2020 $228M +$153M +203% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $75.3M +$6.7M +9.76% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $68.6M +$36.6M +114% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $32M +$31.4M +5371% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $585K -$65.1M -99.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $65.7M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.